SCHEMBL7205226

SCHEMBL7205226

COc1nccc(C(=O)C(=O)c2ccc(F)cc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 4/20 0.47
CES2 O00748 3/20 0.47
MAPK14 Q16539 4/20 0.42
KMT2A Q03164 5/20 0.38
MAPT P10636 4/20 0.38
KDM4E B2RXH2 1/20 0.37
MAPK13 O15264 1/20 0.37
PRKD3 O94806 1/20 0.37
MAP4K4 O95819 1/20 0.37
EGFR P00533 1/20 0.37
RAF1 P04049 1/20 0.37
CYP1A2 P05177 1/20 0.37
LCK P06239 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
PRKCA P17252 1/20 0.37
CYP2C19 P33261 1/20 0.37
FRK P42685 1/20 0.37
MAPK9 P45984 1/20 0.37
CSNK1A1 P48729 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7205324 0.85 MAPK14 (0.39) CES1CES2MAPK14KMT2AMAPT
SCHEMBL7206668 0.81 MAPT (0.44) CES1CES2MAPK14KMT2AMAPT
SCHEMBL10020220 0.80 CES1 (0.52) CES1CES2KMT2AKDM4ECYP1A2
SCHEMBL5771051 0.77 CES1 (0.47) CES1CES2MAPK14KMT2AMAPT
SCHEMBL2015751 0.74 LMNA (0.53) KMT2AMAPTKDM4EALDH1A1LMNA
SCHEMBL17819925 0.74 ALDH1A1 (0.42) KMT2AMAPTKDM4EALDH1A1HPGD
SCHEMBL709768 0.73 CES1 (0.43) CES1CES2MAPK14KMT2AKDM4E
SCHEMBL708025 0.73 CES1 (0.43) CES1CES2MAPK14KMT2AMAPT
SCHEMBL22518516 0.73 MAPK1 (0.44) MAPTKDM4ECYP1A2LCKCYP2C9
SCHEMBL2789425 0.73 NNMT (0.46) MAPK14KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6610695-B1 Prophylaxis or treatment of CSBP/RK/p38 kinase mediated disease SMITHKLINE BEECHAM CORPORATION 2003-08-26 US disclosed
EP-0994870-A4 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM (US) 2002-10-23 EP disclosed
EP-0994870-A1 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS Smithkline Beecham (US) 2000-04-26 EP disclosed
WO-1998057966-A1 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1998-12-23 WO disclosed